Active Stocks

Mon Sept 07 2026 15:59:41

Tata Steel share price
185.50 -1.85%

Kotak Mahindra Bank share price
422.30 -0.60%

Bharat Electronics share price
404.50 -0.17%

HDFC Bank share price
710.80 -0.33%

ITC share price
263.75 -0.13%

Business News > Mint Authors > T. Surendar

T. Surendar

ARTICLES BY T. SURENDAR

RPG's move matters less for its size— ₹215 crore is small by pharma M&A standards—than for who is making it. (Mint)

Capital-conservative RPG turns aggressive buyer in API expansion

4 min read . 06 Sept 2026

“Globally, generics is consolidating,” chief executive Rajeev Nannapaneni told Mint, pointing out that most Western companies have exited the commodity generics space, leaving Indian drugmakers to compete fiercely with each other.

Natco Pharma casts a wider net as generics gets crowded

4 min read . 01 Sept 2026

TAFE vice chair Lakshmi Venu (left) with Mallika Srinivasan, chairperson and managing director of the company.

The mother and daughter behind India’s No. 2 tractor maker bet on a fifth plant

5 min read . 31 Aug 2026

G.V. Prasad, co-chairman and managing director, Dr Reddy’s Laboratories.

After the lottery win: why Dr Reddy’s is seeking a new growth engine

11 min read . 24 Aug 2026

The machinery had jammed just when Noel Tata, chairman of Tata Trusts, which owns around two-third of Tata Sons through SDTT, SRTT and a number of other smaller trusts, was set to take centrestage as the group’s top decisionmaker. (Tarun Kumar Sahu/Mint)

Inside Noel Tata’s unenviable inheritance

10 min read . 20 Aug 2026

IT remains among the most generous dividend-paying sectors because its model generates substantial cash without comparable capital expenditure.

Why India Inc is retaining more of its profits

3 min read . 16 Aug 2026

N. Chandrasekaran, 63, was appointed chair of Tata Sons, the principal investment holding company of the $400-billion Tata Group, in February 2017 and received a second five-year term in 2022. (Reuters)

The ‘no surprises’ ideal: A rift that ended Chandrasekaran's tenure

1 min read . 13 Aug 2026

Ajit Prabhu, founder and chairman of engineering services provider Quest Global.

Inside Ajit Prabhu’s 100-year bet against AI hype

3 min read . 05 Aug 2026

Wockhardt's UK lab. Six of Wockhardt’s molecules carry a US drug regulatory tag that fast-tracks antibiotics aimed at dangerous, hard-to-treat infections.

How three stubborn men delivered India’s first homegrown drugs

14 min read . 27 Jul 2026

Venkat Jasti, promoter and chief executive officer of Suven Life Sciences.

Suven's big neuroscience bet enters final stretch

6 min read . 20 Jul 2026

Glenn Saldanha, chairman and managing director of Glenmark Pharmaceuticals.

Beyond generics: Glenmark plans a bold 10-year pivot to global drug innovation

5 min read . 07 Jul 2026

The PLI scheme was conceptualized to kick-start a rare earth magnet industry in India after China restricted exports of these magnets last year during its trade dispute with the US. (Reuters)

India extends deadline for rare earth magnet incentive scheme by a month

2 min read . 26 Jun 2026

Vedanta's executive vice-chairman Navin Agarwal. (@NavinAgarwal_V/X)

Vedanta's Navin Agarwal bets big on rare earth magnets, sets up firm eyeing PLI

2 min read . 26 Jun 2026

Rare-earths are sometimes called the vitamins of modern industry, used in tiny amounts but impossible to substitute in the things that matter most. (AI modified image)

Why India’s corporate titans are resisting a ₹7,280-cr magnet race

13 min read . 25 Jun 2026

The Bajaj Group’s family council. Clockwise from left: Rajiv, Sanjiv, Nirav, Niraj and Shekhar Bajaj. (Tarun Kumar Sahu/Mint)

At 100, the Bajaj Group is writing a new chapter—on healthcare

9 min read . 20 May 2026

Dilip Shanghvi, executive chairman of Sun Pharma.

Son rise at Sun: Decoding the architecture of Dilip Shanghvi’s global empire

1 min read . 06 May 2026

Shares of Biocon rose after a report said founder and chairperson Kiran Mazumdar-Shaw had identified her niece, Claire Mazumdar, as her successor. (Bloomberg)

Succession buzz lifts Biocon shares, but Kiran Mazumdar-Shaw says 'not imminent'

3 min read . 05 May 2026

Announced early on Monday, the Organon acquisition ranks as the second-largest acquisition by an Indian company, behind Tata Steel's 2007 deal to buy British steel maker Corus Group for $12 billion. (Reuters)

Sun Pharma mega deal for Organon signals fading US generics allure

5 min read . 28 Apr 2026

A view of GIFT City.

The unexpected second purpose of Gujarat's financial hub

9 min read . 13 Apr 2026

Eden Ceramic City, a marketing mall for premium brands in Morbi, wears a deserted look as both local and international customers delay their visits to the city. (T. Surendar)

Inside the unprecedented silence of Morbi

11 min read . 22 Mar 2026